(Q48133076)

9 February 2018

title

Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture (English)

1 reference

9 February 2018

1 reference

6

Arthur E Frankel

1 reference

9 February 2018

Tie Fu Liu

1

1 reference

9 February 2018

Kimberly A Cohen

2

1 reference

9 February 2018

Mark C Willingham

3

1 reference

9 February 2018

Stephen B Tatter

4

1 reference

9 February 2018

Raj K Puri

5

1 reference

9 February 2018

publication date

1 October 2003

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

65

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

77-85

1 reference

9 February 2018

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

cites work

1 reference

12 December 2020

The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex

1 reference

12 December 2020

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail.

1 reference

12 December 2020

Convection-enhanced delivery of macromolecules in the brain

1 reference

12 December 2020

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

1 reference

12 December 2020

A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines

1 reference

12 December 2020

Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates

1 reference

12 December 2020

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malig

1 reference

12 December 2020

Brain, other central nervous system, and eye cancer.

1 reference

12 December 2020

Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy

1 reference

12 December 2020

Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins.

1 reference

12 December 2020

Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6

1 reference

12 December 2020

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

1 reference

12 December 2020

Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment

1 reference

12 December 2020

Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins.

1 reference

12 December 2020

Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.

1 reference

12 December 2020

A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells

1 reference

12 December 2020

Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals

1 reference

12 December 2020

DAB389EGF fusion protein therapy of refractory glioblastoma multiforme

1 reference

12 December 2020

Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells

1 reference

12 December 2020

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

12 December 2020

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells.

1 reference

12 December 2020

Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials

1 reference

12 December 2020

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging

1 reference

12 December 2020

Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells

1 reference

12 December 2020

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

1 reference

12 December 2020

Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.

1 reference

12 December 2020

Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies

1 reference

12 December 2020

hIL-13-PE38QQR. NeoPharm

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

Molecular characterization of key diphtheria toxin:receptor interactions

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026286214901

1 reference

9 February 2018

Dimensions Publication ID

1020805736

0 references

1 reference

9 February 2018